Vaccination with the repeat β-hCG C-terminal peptide carried by heat shock protein-65 (HSP65) for inducing antitumor effects
Jie Yang(China Pharmaceutical University), Rongyue Cao(China Pharmaceutical University), Mingzhu Du(China Pharmaceutical University), Maolei Xu(State Key Laboratory of Natural Medicine), Yan‐Kai Zhang(Beijing University of Technology), Zeyu Wang(Anhui University), Xun Zhang(Zaozhuang University), Jingjing Liu(Tianjin Medical University Cancer Institute and Hospital), Bin Liu(UCSF Helen Diller Family Comprehensive Cancer Center), Jie Wu(Yunnan University), Xiao Huang(China Pharmaceutical University), Taiming Li(China Pharmaceutical University), Zhenqiu Gao(State Key Laboratory of Natural Medicine), Huaqian Wang(China Pharmaceutical University)
Cited by 6
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
|The Journal of Clinical Endocrinology & Metabolism|2003|448
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273